Ipsos Healthcare Launches Lupus Therapy Monitor

Ipsos Healthcare has launched a multi-client Lupus Therapy Monitor in the top 5 EU markets - the UK, France, Germany, Italy and Spain.

The new patient chart audit will enable subscribers to understand and track the treatment of Systemic Lupus Erythematosus across these regions, using Ipsos Healthcare's knowledge of the disease from custom research, together with its Global Therapy Monitors.

The launch expands the business's syndicated Rheumatology portfolio, which also covers Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Non-Radiographic Axial SpA and Peripheral SpA.

Paul O'Meara (pictured), VP of Ipsos Healthcare's Autoimmune Therapy Monitors, comments: 'With the introduction of biologics and the many new players entering the market, this is an exciting stage in the treatment of Systemic Lupus Erythematosus. The new monitor will enable us to reveal actual prescribing practices and patient treatment pathways, together with physician perceptions of current and in-development therapies, product and company attribute associations, and more.'

Web site: www.ipsos.com .

All articles 2006-23 written and edited by Mel Crowther and/or Nick Thomas, 2024- by Nick Thomas, unless otherwise stated.

• Ipsos UK
• All news
• MrWeb info